Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 was added and the previous Revision: v3.4.1 entry was removed. The updates appear to be administrative page maintenance and do not alter study content or results.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status, and updated the site release to v3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedShow glossary option added and metadata labels updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.